03.24.25 -- Testing Federal Healthcare Laws: Risks In Genetic-Testing Programs

Join Cell & Gene: The Podcast Host Erin Harris as she talks with Dr. Simrit Parmar, Founder of Cellenkos, about pioneering umbilical cord blood-derived Treg cell therapies for autoimmune and inflammatory diseases. Discover the advantages of cord blood-derived Tregs, Cellenkos’ CRANE technology, and key insights from their Phase 1b trial for CK0804. Plus, hear about the challenges of scaling off-the-shelf Treg therapies and what’s next for Cellenkos in 2025.

Since life science professionals hail from diverse backgrounds, educations, and work experiences, different mentorship models serve their varied development needs and learning styles.

Delve into the logistical and financial obstacles faced by stakeholders in clinical trials, highlighting the need for balance in improving the participant experience while managing operational efficiency.

Transform the clinical trial experience through a Patient Kindness initiative that encourages sponsors and sites to recognize participants as individuals, fostering empathy and personalized support.

Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.

Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar.